MedTrace Logo

Urinary Catheterization and Second Stage of Labor

NCT02198157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 184

Last updated 2016-02-23

No results posted yet for this study

Summary

* Labor is divided into three stages: the first stage is from labor onset until full dilation, second stage is from full dilation until delivery of the baby, and the third stage from the delivery of the baby until the delivery of the placenta
* The mean duration of second stage in nulliparas as defined by the American college of obstetricians and gynecologists (ACOG) is 54 minutes
* Epidural anesthesia is a known cause for prolongation of the second stage of labor. Prolonged second stage in nullipara women with epidural is defined as more than 3 hours, and more than 2 hours in those without epidural.
* Although perinatal outcome is not compromised with a prolonged second stage , there is evidence that maternal morbidities such as perineal trauma, chorioamnionitis ,instrumental delivery and postpartum hemorrhage increase with prolonged second stage
* Another effect of epidural anesthesia during labor is urinary retention and a need for catheterization.
* Full bladder may behave as a tumor previa and interfere to fetal head descent in the birth canal, increasing by that the duration of the second stage.
* This study aims to investigate the effect of intermittent versus continuous catheterization on the duration of the second stage of labor

Conditions

  • Labor, Second Stage

Interventions

OTHER

urinary catheterization

nullipara women with epidural anaesthesia who pose urination difficulty will be randomize to receive intermittent or continuous urinary catheterization.

Sponsors & Collaborators

  • Raed Salim

    lead OTHER

Principal Investigators

  • raed salim, MD · Dep. OB/GYN, HaEmek Medical Center, Afula, Israel

  • abeer suleiman, MD · Dep. OB/GYN, HaEmek Medical Center, Afula, Israel

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2014-07-31
Primary Completion
2015-05-31
Completion
2015-07-31

Countries

  • Israel

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02198157 on ClinicalTrials.gov